Dr Martens makes positive strides, confirms full-year guidance
Full-year guidance confirmedAmericas back in growthInvestors remain scepticalIconic footwear brand Dr Martens (DOCS) confirmed its 2025 outlook and said third quarter trading was in line with expectations, with US DTC (direct to...
27 January 2025